Endothelins and their receptors in cancer: identification of therapeutic targets. - Wikidata - awgldk - TriplyDB

Endothelins and their receptors in cancer: identification of therapeutic targets.

Endothelins and their receptors in cancer: identification of therapeutic targets.

http://www.wikidata.org/entity/Q37830914

about

Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through ETA receptor Biomarkers for Diabetic Retinopathy - Could Endothelin 2 Be Part of the Answer?Epigenetic inactivation of endothelin-2 and endothelin-3 in colon cancer.Antiangiogenic therapy for cancer: an update Why are epididymal tumours so rare?Activation of ETA Receptor by Endothelin-1 Induces Hepatocellular Carcinoma Cell Migration and Invasion via ERK1/2 and AKT Signaling Pathways.Endothelin causes transactivation of the EGFR and HER2 in non-small cell lung cancer cells.Evaluation of somatostatin, CXCR4 chemokine and endothelin A receptor expression in a large set of paragangliomas.Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia.

P2860

Q28539394-B85D13F0-0CC6-49E4-8EF0-3F9B9085801F Q36092355-0BC7A82E-C3DE-46A4-8E99-8152B1B6E4FE Q36405934-729A681B-44E3-4E7D-9045-F6FB9344AF8D Q36563542-52F20FE0-831B-4401-9020-9B2438251400 Q37037784-0DEAD7DB-BF73-4A00-A122-5E170DDCC73C Q38824920-D60B7BD7-0B6A-48BE-9D62-69F360CFF94C Q46424042-BD1CC035-635B-4859-8BA5-C80E9AFB3666 Q47108225-E834FAAF-DF2F-4D64-909B-9F4C655F2AD0 Q47147169-D3BADA11-1DA4-4377-8D80-DC9C9C7556FF

P2860

Endothelins and their receptors in cancer: identification of therapeutic targets.

http://www.wikidata.org/entity/Q37830914

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 January 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Endothelins and their receptors in cancer: identification of therapeutic targets.

@en

Endothelins and their receptors in cancer: identification of therapeutic targets.

@nl

type

label

Endothelins and their receptors in cancer: identification of therapeutic targets.

@en

Endothelins and their receptors in cancer: identification of therapeutic targets.

@nl

prefLabel

Endothelins and their receptors in cancer: identification of therapeutic targets.

@en

Endothelins and their receptors in cancer: identification of therapeutic targets.

@nl

P1433

Q37830914-A740CB3C-7B99-4C9D-BFC8-8B8DC41902BB

P1476

Q37830914-01D78E41-A4D8-4654-8D7A-CC5A00BBDCA6

P2093

Q37830914-EE7B3A73-74C3-4724-BCEA-F3B18AFC620A

Q37830914-F2E324BE-E1C8-4F19-9D5B-96855CDCD573

P2860

Q37830914-04B176FE-77D9-4600-9B1E-260CADC8FD5B

Q37830914-058D4649-31C0-4861-BFAB-5C3607BEA189

Q37830914-11B1483B-6CFF-4538-BFEF-8176AC7D1317

Q37830914-19B3D7F5-0C7C-4F7D-B8B1-990CF924EE86

Q37830914-20F76B34-479E-4198-AE73-E48DEE12F9FD

Q37830914-21BD6883-516C-4B6B-A344-49698598C8B0

Q37830914-242DB419-8B0F-4343-83CC-2070CE3061F9

Q37830914-323A2BF7-5806-4B6B-AAFB-9C6827B242B0

Q37830914-326299B5-FAC0-4FB2-8F51-C89D9A71A29D

Q37830914-38FD44C9-4871-45AE-9587-12C6CF6B772A

P304

Q37830914-F35CFCE7-72FD-4318-80F8-94D8A39DE752

P31

Q37830914-4E02BE82-214C-49A4-ADEC-E1591D8142D3

P356

Q37830914-EB70B3B4-6E64-4CDB-92DC-E1E84B9BFA03

P433

Q37830914-530E43B4-A09A-403E-B5B3-6CB1B634C359

P478

Q37830914-C4F4BBBD-DC4F-47B3-AD1E-AF84386E8472

P577

Q37830914-121D0838-7450-4075-AEBD-FD6F8E1A6053

P5875

Q37830914-A1AB594B-37B1-4280-BBBC-3200B7664BE0

P698

Q37830914-998EDFB0-1D05-4D79-9FF4-9BFEF1A5824A

P932

Q37830914-2D7B1998-3A09-4945-9240-3375F5710EA7

P356

J.PHRS.2011.01.002

P1433

Pharmacological Research

P1476

Endothelins and their receptors in cancer: identification of therapeutic targets.

@en

P2093

Roderick H Dashwood

http://www.w3.org/2001/XMLSchema#string

Rong Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Dietary histone deacetylase inhibitors: from cells to mice to man

Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis

The endothelin axis: emerging role in cancer

The endothelin axis in cancer

Potent and selective non-peptidic inhibitors of endothelin-converting enzyme-1 with sustained duration of action

Endothelins in bone cancer metastases.

Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia-inducible factor-1alpha in melanoma cells.

Novel targeted therapeutics for metastatic castration-resistant prostate cancer.

A randomized, double-blind, placebo-controlled study of high-dose bosentan in patients with stage IV metastatic melanoma receiving first-line dacarbazine chemotherapy.

Endothelin B receptor, a new target in cancer immune therapy.

P304

519-524

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PHRS.2011.01.002

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49771603

http://www.w3.org/2001/XMLSchema#string

P698

21251982

http://www.w3.org/2001/XMLSchema#string

P932

3109221

http://www.w3.org/2001/XMLSchema#string